Microdose GLP-1 in 2026: programs, cost, and what the evidence says
Verified July 2026: 12 telehealth providers offer microdose GLP-1 programs, with published tiers starting at $79/month. Be clear on one thing before comparing prices: microdosing is an off-label, evidence-light practice. No large published trial supports it.
The weight-loss evidence for these drugs comes from standard doses, 14.9% in STEP-1 (semaglutide 2.4mg) and up to 20.9% in SURMOUNT-1 (tirzepatide 15mg). Microdose claims have not been FDA-reviewed.
These programs are being sold today at real prices anyway. So this page gives you both halves: the honest evidence picture, and a verified price comparison of every microdose program we track.
7.2/10 score. Tirzepatide microdose program.
Read our full Galareview →What is GLP-1 microdosing?
GLP-1 microdosing means taking less than the FDA-approved dose schedule. A typical example: 0.1 to 0.5mg of semaglutide per week, versus the 2.4mg weekly maintenance dose the trials tested.
It is an off-label practice. The FDA has not reviewed or approved any microdose protocol, and each program defines "microdose" its own way.
Most microdose programs use compounded GLP-1s. Compounded drugs are not FDA-approved products.
Programs sell microdosing for three reasons: gentler side effects, lower cost, and maintenance after weight loss. Each claim is plausible. None is proven in a large trial.
What does the evidence actually say?
No large randomized trial has tested GLP-1 microdosing for weight loss as of July 2026. The evidence base for these drugs comes entirely from standard doses.
In STEP-1, semaglutide 2.4mg weekly produced 14.9% average weight loss over 68 weeks, versus 2.4% on placebo.
In SURMOUNT-1, tirzepatide produced 15.0% weight loss at 5mg, 19.5% at 10mg, and 20.9% at 15mg over 72 weeks. Note the pattern: even inside the trial, lower dose meant less weight loss. Microdose tiers sit far below the lowest dose tested.
The trials also enrolled people with BMI 30+, or 27+ with a weight-related condition. Some microdose programs market to BMI as low as 22. Below the trial range, there is no efficacy evidence at any dose.
Hospital systems and academic medical centers that have written about microdosing describe it consistently: interesting, unproven, and driven by cost and side-effect concerns rather than data. We think that skepticism is warranted, and we'd rather tell you that than sell you certainty nobody has.
Which providers offer microdose GLP-1 programs?
Sorted by published microdose tier price, cheapest first. Programs without a published microdose price are listed last.
| # | Provider | Microdose Price | What's Microdosed | Score | |
|---|---|---|---|---|---|
| 1 | Maximus #45 overall | $79/mo | Semaglutide + tirzepatide | 7.1/10 | Visit |
| 2 | AgelessRx #46 overall | $79/mo | GLP-1 (program-defined) | 7/10 | Visit |
| 3 | Mochi Health #18 overall | $99/mo | Semaglutide | 7.7/10 | Visit |
| 4 | Noom Med #27 overall | $99/mo | GLP-1 (program-defined) | 7.4/10 | Visit |
| 5 | Found #36 overall | $99/mo | GLP-1 (program-defined) | 7.3/10 | Visit |
| 6 | Gala #39 overall | $149/mo | Tirzepatide | 7.2/10 | Visit |
| 7 | Enhance MD #16 overall | $169/mo | Tirzepatide | 7.8/10 | Visit |
| 8 | Lemonaid Health #42 overall | $199/mo | Semaglutide + tirzepatide | 7.2/10 | Visit |
| 9 | Telos RX #51 overall | $199/mo | Tirzepatide | 4/10 | Visit |
| 10 | bmiMD #6 overall | from $119/mo* | GLP-1 (program-defined) | 8/10 | Visit |
| 11 | LivBody #52 overall | from $179/mo* | Semaglutide + tirzepatide | 2.9/10 | Visit |
| 12 | Eden Health GLP-1 #1 overall | from $249/mo* | GLP-1 (program-defined) | 8.9/10 | Visit |
*No published microdose-specific tier. The provider's base program price is shown, confirm the microdose price on their site or in our review.
Most microdose programs use compounded semaglutide or tirzepatide from 503A pharmacies. Compounded drugs are not FDA-approved as finished products, and quality control varies by pharmacy.
Microdosing adds a second layer: the dose itself also falls outside the FDA-approved schedule. Verify any provider through our FDA safety checker and read our brand vs compounded guide before enrolling.
Who might microdosing fit, and who should skip it?
Worth a conversation with a clinician if:
- •You stopped a standard dose because of side effects like nausea, and your prescriber wants to try a gentler protocol.
- •You reached your goal weight and your clinician is weighing a lower maintenance dose against stopping entirely.
- •You want a lower-cost, lower-dose entry point and you genuinely understand the evidence gap described above.
Skip microdosing if:
- •You want the weight loss the trials showed. That evidence comes from standard doses only.
- •You have obesity-related conditions where a proven treatment effect matters. Off-label experimentation is not the place to start.
- •You expect FDA-reviewed dosing. No microdose protocol has been through FDA review.
Frequently Asked Questions
What is GLP-1 microdosing?+
Does microdosing GLP-1 work for weight loss?+
How much does a microdose GLP-1 program cost?+
Is microdose GLP-1 FDA-approved?+
Is microdosing GLP-1 safer than standard dosing?+
Who offers tirzepatide microdosing?+
Next step: read our full Gala review (our top microdose pick), or take the 2-minute match quiz to find the right provider, standard dose or microdose, for you.